Objective
Our innovation is constituted by a family of smart inverters (Greenverters) with power ratings of 5, 10, 20 and 50kW that can convert electrical energy from various sources (e.g. solar, wind) to the power grid while improving the power quality. The innovative control structure can realise distributed generation of power from small, domestic renewable energy sources. Our cutting edge controller is capable of optimizing the working point of energy production, maintaining the optimal energy balance, implementing active power factor correction and lowering the extant harmonic distortion in power lines. In addition, it compensates the asymmetry as well as improves the power factor. This increases the lifetime of supplied electrical equipment and devices, reduces the damages, reduces the load of transformers, decreases the losses of energy transfer and enhances the overall efficiency. In addition, Greenverter also helps to significantly reduce extra penalties (typically between 25-50% of electricity bill) imposed by network operators to companies because of the poor power quality consumption (demand charge, penalty on low power factor). Greenverter’s energy optimization also reduces the harmful electromagnetic emissions and thus has a positive impact on the environment. In the Phase 1 project we aim to carry out a feasibility study to prove the technological and economic viability of our project. The success of this proposal will promote the growth of our company.
Fields of science
- engineering and technologyenvironmental engineeringenergy and fuelsrenewable energy
- natural sciencesearth and related environmental sciencesenvironmental sciencespollution
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectrical engineeringpower engineeringelectric power transmission
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
8200 VESZPREM
Hungary
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.